Search peptides, terms, sources/

Peptides (34)

Every peptide in the reference. Filter by UK status, best study type, family or research area.

Filter
UK status
Best study type
Family
Research area

34 of 34 peptides

  • Abaloparatide

    Synthetic 34-amino-acid peptide modelled on PTHrP, studied for osteoporosis. UK prescription-only medicine; the main trial compared it with placebo.

    Hormonal signallingHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • Afamelanotide

    Synthetic alpha-MSH analogue studied in erythropoietic protoporphyria (EPP). Licensed in the UK for adults with EPP; not recommended for routine NHS use. Not the same as Melanotan II.

    MelanocortinHuman trialsEvidence reviewed
    ModerateLicensed UK medicine
  • AOD-9604hGH Fragment 176-191

    Growth hormone fragment studied for weight management. Not licensed in the UK; its largest human trial showed no significant weight-loss benefit.

    Growth hormone axisHuman trialsEvidence reviewed
    ModerateNot licensed in the UK
  • BPC-157Body Protection Compound-157

    Synthetic gastric-derived peptide studied in animal models of tissue healing. Not licensed in the UK; human evidence is one small uncontrolled study.

    Repair and regenerationHuman observationalEvidence reviewed
    LimitedNot licensed in the UK
  • CagrilintideAM833

    Not licensed in the UK. Investigational long-acting amylin analogue studied for weight management, alone and with semaglutide.

    Metabolic and incretinHuman trialsEvidence reviewed
    ModerateNot licensed in the UK
  • CJC-1295CJC-1295 with DAC

    Long-acting growth-hormone-releasing hormone analogue studied for hormone levels in healthy adults. Not licensed in the UK; human evidence is small, short trials.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • Elamipretide

    Synthetic four-amino-acid peptide studied in rare mitochondrial diseases. US accelerated approval for Barth syndrome; not authorised in the UK. A large phase 3 trial failed.

    Immune and longevityHuman trialsEvidence reviewed
    PreliminaryNot licensed in the UK
  • EpithalonEpitalon

    Synthetic four-amino-acid peptide studied in ageing research. Not licensed in the UK; evidence is mostly laboratory and animal work from one group.

    Immune and longevityHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • GHK-CuCopper peptide GHK

    Copper-binding tripeptide studied for skin ageing and wound healing. Topical cosmetic use; no licensed injectable product in the UK.

    Repair and regenerationHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • GHRP-2Pralmorelin

    Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK; Japan licenses it only as a diagnostic test. No trial shows a health benefit.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • GHRP-6Growth hormone-releasing…

    Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK. Human studies are short hormone-response and diagnostic work; no trial shows a health benefit.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • HexarelinExamorelin

    Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK. In a long-term human study the response faded and IGF-I and body composition did not change.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • IpamorelinIPA

    Synthetic growth hormone secretagogue studied for growth hormone release. Not licensed in the UK; human evidence is one small pharmacokinetic study.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • KisspeptinMetastin

    Natural reproductive hormone studied in UK trials for low sexual desire and IVF egg maturation. No UK marketing authorisation identified.

    Hormonal signallingHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • KPVLys-Pro-Val

    Three-amino-acid fragment of alpha-MSH, studied in cell and mouse models of inflammation. Not licensed in the UK. No human trial of KPV was found.

    Immune and longevityAnimal studiesEvidence reviewed
    PreliminaryNot licensed in the UK
  • Liraglutide

    Earlier-generation GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; licence status depends on the brand.

    Metabolic and incretinHuman trialsEvidence reviewed
    ModerateLicensed UK medicine
  • Mazdutide

    Not authorised in the UK; approved in China. Peptide that activates glucagon and GLP-1 receptors, studied in phase 3 trials in Chinese adults.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongNot licensed in the UK
  • Melanotan IIMT-II

    Synthetic melanocortin receptor agonist studied for skin tanning. Not licensed in the UK; human evidence is a three-volunteer pilot plus case reports.

    MelanocortinHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • MOTS-cMitochondrial open reading…

    16-amino-acid peptide encoded in mitochondrial DNA, studied in mice and cells. Not licensed in the UK. No published trial gave MOTS-c to people; human studies measured the body's own levels.

    Immune and longevityHuman trialsEvidence reviewed
    PreliminaryNot licensed in the UK
  • Oxytocin

    Natural hormone licensed in the UK for obstetric use; studied separately for social cognition, with mostly negative trial results.

    Hormonal signallingHuman trialsEvidence reviewed
    LimitedLicensed for a different use
  • PT-141 (Bremelanotide)Bremelanotide

    No UK marketing authorisation found; authorised in the US. Selective melanocortin-4 receptor agonist studied for low sexual desire in women.

    MelanocortinHuman trialsEvidence reviewed
    StrongNot licensed in the UK
  • RetatrutideLY3437943

    Investigational triple GIP, GLP-1 and glucagon receptor agonist studied for weight management. Not licensed in the UK; studied in a Phase 2 trial.

    Metabolic and incretinHuman trialsEvidence reviewed
    ModerateNot licensed in the UK
  • SelankTP-7

    Synthetic tuftsin-derived peptide studied for anxiety. Not licensed in the UK; main human evidence is one active-comparator trial.

    Brain and moodHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • Semaglutide

    GLP-1 receptor agonist studied in type 2 diabetes, weight management and cardiovascular outcomes. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • SemaxACTH heptapeptide analog

    Synthetic ACTH-derived peptide studied for brain function and stroke recovery. Not licensed in the UK; evidence is mainly rodent studies.

    Brain and moodHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • SermorelinSermorelin acetate

    Synthetic growth-hormone-releasing hormone fragment studied in children with growth hormone deficiency. Not licensed in the UK; evidence is mainly from before 2000.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • Setmelanotide

    Synthetic peptide that activates the MC4 receptor, studied in rare forms of obesity. UK prescription-only medicine for three rare conditions; trials were small and do not cover common obesity.

    MelanocortinHuman trialsEvidence reviewed
    ModerateLicensed UK medicine
  • Survodutide

    Investigational peptide that activates glucagon and GLP-1 receptors. Not authorised in the UK. Studied in phase 3 trials, all sponsor-funded.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongNot licensed in the UK
  • TB-500Thymosin Beta-4 fragment

    Short synthetic fragment linked to thymosin beta-4. Not licensed in the UK. No human trials of TB-500 itself were found; trials of the full-length protein are not evidence for it.

    Repair and regenerationAnimal studiesEvidence reviewed
    LimitedNot licensed in the UK
  • Teriparatide

    34-amino-acid fragment of parathyroid hormone, studied for osteoporosis. UK prescription-only medicine; trials looked at spine and hip fractures.

    Hormonal signallingHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • TesamorelinTH9507

    Not licensed in the UK. Growth-hormone-releasing hormone analogue studied for visceral fat in HIV-associated lipodystrophy, in randomised trials.

    Growth hormone axisHuman trialsEvidence reviewed
    StrongNot licensed in the UK
  • Thymosin Alpha-1Thymalfasin

    Immune-regulating peptide studied in sepsis, pancreatitis and hepatitis B. Not licensed in the UK; meta-analyses show mixed results.

    Immune and longevityHuman trialsEvidence reviewed
    ModerateNot licensed in the UK
  • Thymosin beta-4Thymosin β4

    Natural 43-amino-acid peptide studied in eye and wound-healing trials. Not licensed in the UK. Trials were small with mixed results. It is not TB-500.

    Repair and regenerationHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • Tirzepatide

    Dual GIP and GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.